← Leaderboards
Paul Hanissian
Reia, Llc
$5,185,645
Attributed
$5,185,645
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,185,645 · 2
By mechanism
R44$5,035,645 · 1
R43$150,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Vagina”
- Soumya Rahima Benhabbour · Univ Of North Carolina Chapel Hill$9,107,493
- Keiichiro Kushiro · Mucommune, Llc$6,005,121
- Tal Korem · Columbia University Health Sciences$4,999,388
- Leah Johnson · Research Triangle Institute$4,789,398
- Holly Rockweiler · Madorra, Inc.$4,300,000
- Tanya Christineh Petrossian · Endomet Biosciences, Inc$3,887,132
Research focus
VaginaResourcesOrganUterusWomanConnective TissueInnovationOperative Surgical ProceduresPelvic Organ ProlapseUnited StatesEvaluationMedical DeviceDesignEquipmentAffectExcisionMedicalMuscleAlternative TreatmentPelvic Floor StructurePessariesHand OsteoarthritisBiomaterial CompatibilityDevices
Grant awards (7)
Non-surgical treatment option for pelvic organ prolapse$995,757
R44 · FY2025 · HD · contact PI
Non-surgical treatment option for pelvic organ prolapse$999,169
R44 · FY2024 · HD · contact PI
Non-surgical treatment option for pelvic organ prolapse$994,718
R44 · FY2023 · HD · contact PI
Non-surgical treatment option for pelvic organ prolapse$891,138
R44 · FY2021 · HD · contact PI
Non-surgical treatment option for pelvic organ prolapse$160,845
R44 · FY2021 · HD · contact PI
Non-surgical treatment option for pelvic organ prolapse$994,018
R44 · FY2020 · HD · contact PI
Non-surgical treatment option for pelvic organ prolapse$150,000
R43 · FY2018 · HD · contact PI